Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid TherapyCrews, Kristine R. ; Monte, Andrew A. ; Huddart, Rachel ; Caudle, Kelly E. ; Kharasch, Evan D. ; Gaedigk, Andrea ; Dunnenberger, Henry M. ; Leeder, J. Steven ; Callaghan, John T. ; Samer, Caroline Flora ; Klein, Teri E. ; Haidar, Cyrine E. ; Van Driest, Sara L. ; Ruano, Gualberto ; Sangkuhl, Katrin ; Cavallari, Larisa H. ; Müller, Daniel J. ; Prows, Cynthia A. ; Nagy, Mohamed ; Somogyi, Andrew A. ; Skaar, Todd C.Clinical pharmacology and therapeutics, 2021-10, Vol.110 (4), p.888-896 [Periódico revisado por pares]United StatesTexto completo disponível |
|
2 |
Material Type: Artigo
|
Pharmacogenetics of P2Y12 receptor inhibitorsThomas, Cameron D. ; Williams, Alexis K. ; Lee, Craig R. ; Cavallari, Larisa H.Pharmacotherapy, 2023-02, Vol.43 (2), p.158-175 [Periódico revisado por pares]Texto completo disponível |
|
3 |
Material Type: Artigo
|
Ethnicity-specific pharmacogenetics: the case of warfarin in African AmericansHernandez, W ; Gamazon, E R ; Aquino-Michaels, K ; Patel, S ; O'Brien, T J ; Harralson, A F ; Kittles, R A ; Barbour, A ; Tuck, M ; McIntosh, S D ; Douglas, J N ; Nicolae, D ; Cavallari, L H ; Perera, M AThe pharmacogenomics journal, 2014-06, Vol.14 (3), p.223-228 [Periódico revisado por pares]United States: Nature Publishing GroupTexto completo disponível |
|
4 |
Material Type: Artigo
|
Anticoagulation Endpoints With Clinical Implementation of Warfarin Pharmacogenetic Dosing in a Real‐World Setting: A Proposal for a New Pharmacogenetic Dosing ApproachArwood, MJ ; Deng, J ; Drozda, K ; Pugach, O ; Nutescu, EA ; Schmidt, S ; Duarte, JD ; Cavallari, LHClinical pharmacology and therapeutics, 2017-05, Vol.101 (5), p.675-683 [Periódico revisado por pares]United StatesTexto completo disponível |
|
5 |
Material Type: Artigo
|
The Missing Association: Sequencing‐Based Discovery of Novel SNPs in VKORC1 and CYP2C9 That Affect Warfarin Dose in African AmericansPerera, MA ; Gamazon, E ; Cavallari, LH ; Patel, SR ; Poindexter, S ; Kittles, RA ; Nicolae, D ; Cox, NJClinical pharmacology and therapeutics, 2011-03, Vol.89 (3), p.408-415 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
|
6 |
Material Type: Artigo
|
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare SystemsLuzum, JA ; Pakyz, RE ; Elsey, AR ; Haidar, CE ; Peterson, JF ; Whirl‐Carrillo, M ; Handelman, SK ; Palmer, K ; Pulley, JM ; Beller, M ; Schildcrout, JS ; Field, JR ; Weitzel, KW ; Cooper‐DeHoff, RM ; Cavallari, LH ; O'Donnell, PH ; Altman, RB ; Pereira, N ; Ratain, MJ ; Roden, DM ; Embi, PJ ; Sadee, W ; Klein, TE ; Johnson, JA ; Relling, MV ; Wang, L ; Weinshilboum, RM ; Shuldiner, AR ; Freimuth, RRClinical pharmacology and therapeutics, 2017-09, Vol.102 (3), p.502-510 [Periódico revisado por pares]United StatesTexto completo disponível |
|
7 |
Material Type: Artigo
|
How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A TutorialCicali, Emily J. ; Elchynski, Amanda L. ; Cook, Kelsey J. ; Houder, John T. ; Thomas, Cameron D. ; Smith, D. Max ; Elsey, Amanda ; Johnson, Julie A. ; Cavallari, Larisa H. ; Wiisanen, KristinClinical pharmacology and therapeutics, 2021-09, Vol.110 (3), p.677-687 [Periódico revisado por pares]Texto completo disponível |
|
8 |
Material Type: Artigo
|
Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and ProjectsVolpi, Simona ; Bult, Carol J. ; Chisholm, Rex L. ; Deverka, Patricia A. ; Ginsburg, Geoffrey S. ; Jacob, Howard J. ; Kasapi, Melpomeni ; McLeod, Howard L. ; Roden, Dan M. ; Williams, Marc S. ; Green, Eric D. ; Rodriguez, Laura Lyman ; Aronson, Samuel ; Cavallari, Larisa H. ; Denny, Joshua C. ; Dressler, Lynn G. ; Johnson, Julie A. ; Klein, Teri E. ; Leeder, J. Steven ; Piquette‐Miller, Micheline ; Perera, Minoli ; Rasmussen‐Torvik, Laura J. ; Rehm, Heidi L. ; Ritchie, Marylyn D. ; Skaar, Todd C. ; Wagle, Nikhil ; Weinshilboum, Richard ; Weitzel, Kristin W. ; Wildin, Robert ; Wilson, John ; Manolio, Teri A. ; Relling, Mary V.Clinical pharmacology and therapeutics, 2018-05, Vol.103 (5), p.778-786 [Periódico revisado por pares]United StatesTexto completo disponível |
|
9 |
Material Type: Artigo
|
NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trialDumeny, Leanne ; Vardeny, Orly ; Edelmann, Frank ; Pieske, Burkert ; Duarte, Julio D. ; Cavallari, Larisa H.Pharmacotherapy, 2021-12, Vol.41 (12), p.978-987 [Periódico revisado por pares]United States: Wiley Subscription Services, IncTexto completo disponível |
|
10 |
Material Type: Artigo
|
Impact of the ABCD‐GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi‐Site, Real‐World InvestigationThomas, Cameron D. ; Franchi, Francesco ; Keeley, Ellen C. ; Rossi, Joseph S. ; Winget, Marshall ; David Anderson, R. ; Dempsey, Alyssa L. ; Gong, Yan ; Gower, Megan N. ; Kerensky, Richard A. ; Kulick, Natasha ; Malave, Jean G. ; McDonough, Caitrin W. ; Mulrenin, Ian R. ; Starostik, Petr ; Beitelshees, Amber L. ; Johnson, Julie A. ; Stouffer, George A. ; Winterstein, Almut G. ; Angiolillo, Dominick J. ; Lee, Craig R. ; Cavallari, Larisa H.Clinical pharmacology and therapeutics, 2022-07, Vol.112 (1), p.146-155 [Periódico revisado por pares]United StatesTexto completo disponível |